We have previously found the induction of MuRF-1 and Atrogin-1 gene expression during cachexia progression, and systemic IL-6 inhibition can suppress muscle protein degradation in ApcMin/+ mice [27]. This evidence concerns the gene FBXO32 and Cachexia.